Retraction
Therapeutic potential of targeting IRES-dependent c-myc translation in multiple myeloma cells during ER stress
Paper Information
Record ID:
47243
Author(s):
Journal:
Publication Date:
May 11, 2015
Retraction Date:
August 31, 2023
(2.2 years years ago)
Subjects:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Not indexed in PubMed
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1038/s41388-023-02820-5Additional Notes:
see also: https://pubpeer.com/publications/7041D5E3ABAF04BC7CB3731371F879 ; Alan Lichtenstein has VA finding of misconduct: see https://www.federalregister.gov/documents/2024/11/18/2024-26756/findings-of-research-misconduct-c;
Citations (68)
68
Total Citations4
Post-Retraction(5.9%)
64
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
387
Days since retraction (latest)
Identification of the TXNIP IRES and characterization of the impact of regulatory IRES trans-acting factors
Sebastian Lampe, Michael M. Kunze, Anica Scholz et al. (11 authors)
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Published: Jan 2018
14 citations
14 citations
2038 days before retraction
MYC and tumor metabolism: chicken and egg
Francesca R. Dejure, Martin Eilers
The EMBO Journal
Open Access
Published: Nov 2017
210 citations
210 citations
2119 days before retraction
Erratum: New frontiers in translational control of the cancer genome
Morgan Truitt, Davide Ruggero
Nature reviews. Cancer
Open Access
Published: Apr 2017
311 citations
311 citations
2320 days before retraction
Applying a high-throughput fluorescence polarization assay for the discovery of chemical probes blocking La:RNA interactions in vitro and in cells
Gunhild Sommer, Alena Fedarovich, Venkatesh Kota et al. (6 authors)
PLoS ONE
Open Access
Published: Mar 2017
11 citations
11 citations
2361 days before retraction
Rapamycin promotes differentiation increasing βIII-tubulin, NeuN, and NeuroD while suppressing nestin expression in glioblastoma cells
Michela Ferrucci, Francesca Biagioni, Paola Lenzi et al. (12 authors)
Oncotarget
Open Access
Published: Mar 2017
28 citations
28 citations
2369 days before retraction
Methylarginines within the RGG-Motif Region of hnRNP A1 Affect Its IRES Trans-Acting Factor Activity and Are Required for hnRNP A1 Stress Granule Localization and Formation
Michael L. Wall, Stephen M. Lewis
Journal of Molecular Biology
Published: Dec 2016
72 citations
72 citations
2452 days before retraction
More than just scanning: the importance of cap-independent mRNA translation initiation for cellular stress response and cancer
Rafaela Lacerda, Juliane Menezes, Luı́sa Romão
Cellular and Molecular Life Sciences
Open Access
Published: Dec 2016
124 citations
124 citations
2463 days before retraction
A researcher’s guide to the galaxy of IRESs
Ilya M. Terenin, Victoria V. Smirnova, Dmitry E. Andreev et al. (5 authors)
Cellular and Molecular Life Sciences
Open Access
Published: Nov 2016
66 citations
66 citations
2479 days before retraction
Translating Hedgehog in Cancer: Controlling Protein Synthesis
Davide D’Amico, Gianluca Canettieri
Trends in Molecular Medicine
Published: Sep 2016
14 citations
14 citations
2547 days before retraction
New insights into the unfolded protein response in stem cells
Yanzhou Yang, Hoi‐Hung Cheung, Jiajie Tu et al. (5 authors)
Oncotarget
Open Access
Published: Jun 2016
35 citations
35 citations
2642 days before retraction
Mechanistic Target of Rapamycin (mTOR) Inhibition Synergizes with Reduced Internal Ribosome Entry Site (IRES)-mediated Translation of Cyclin D1 and c-MYC mRNAs to Treat Glioblastoma
Brent Holmes, Jihye Lee, Kenna A. Landon et al. (8 authors)
Journal of Biological Chemistry
Open Access
Published: May 2016
44 citations
44 citations
2667 days before retraction
New frontiers in translational control of the cancer genome
Morgan Truitt, Davide Ruggero
Nature reviews. Cancer
Open Access
Published: Apr 2016
333 citations
333 citations
2683 days before retraction
Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells
Chao Zhang, Lei Yang, Yadi Geng et al. (10 authors)
Oncotarget
Open Access
Published: Apr 2016
17 citations
17 citations
2708 days before retraction
Targeting MYC in cancer therapy: RNA processing offers new opportunities
Cheryl M. Koh, Arianna Sabò, Ernesto Guccione
BioEssays
Open Access
Published: Jan 2016
71 citations
71 citations
2782 days before retraction
Cap-Independent Translation in Hematological Malignancies
Emilie Horvilleur, Lindsay A. Wilson, Amandine Bastide et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Dec 2015
6 citations
6 citations
2810 days before retraction
Could the eIF2α-Independent Translation Be the Achilles Heel of Cancer?
Martin Holčı́k
Frontiers in Oncology
Open Access
Published: Nov 2015
62 citations
62 citations
2835 days before retraction
Exploring Internal Ribosome Entry Sites as Therapeutic Targets
Anton A. Komar, Maria Hatzoglou
Frontiers in Oncology
Open Access
Published: Oct 2015
59 citations
59 citations
2872 days before retraction
Endoplasmic reticulum stress-mediated pathways to both apoptosis and autophagy: Significance for melanoma treatment
Mohamed Hassan
World Journal of Experimental Medicine
Open Access
Published: Jan 2015
30 citations
30 citations
3164 days before retraction
Quick Stats
Total Citations:
68
Years Since Retraction:
2.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025